Building a New Field of Computational Psychiatry. by Moutoussis, M et al.
                             Elsevier Editorial System(tm) for Biological 
Psychiatry 
                                  Manuscript Draft 
 
 
Manuscript Number:  
 
Title: Building a New Field of Computational Psychiatry  
 
Article Type: Invited Commentary 
 
Corresponding Author: Dr. Michael Moutoussis,  
 
Corresponding Author's Institution: WTCN, University College London 
 
First Author: Michael Moutoussis 
 
Order of Authors: Michael Moutoussis; Eran Eldar, PhD; Raymond J Dolan, 
FRS 
 
 
 
 
 
 
1 
Building a New Field of Computational Psychiatry 
 
Michael Moutoussis
1*
, Eran Eldar
1
 & Raymond J. Dolan
12
 
 
 
1 
Wellcome Trust Centre for Neuroimaging, University College London, London WC1N 3BG, United 
Kingdom 
2 
Max Planck – UCL Centre for Computational Psychiatry and Ageing Research, London WC1B 5EH, 
United Kingdom 
* 
Correspondence: m.moutoussis@ucl.ac.uk  
 
Keywords: Computational psychiatry; paradigm validity; individual variability; mental health 
stakeholders. 
 
Computational psychiatry is a flourishing, yet relatively novel, branch of psychiatric research. It 
represents an integrative approach to psychopathology that draws on advances in systems neuroscience, 
decision-making based on probabilistic principles, as well as on advances in biological and 
computational neural network research and novel epidemiological approaches. At this stage in its 
evolution it has yielded few clinically useful insights. We argue that progress in this domain can be 
improved by more ecologically valid studies, including the use of more affectively relevant tasks as 
well as the acquisition of real-world (e.g. experience sampling) data. Furthermore, progress can be 
enhanced by specifically targeting relevant individual variability. The field might also benefit from a 
renewed focus on therapeutic recovery research, a domain that has been neglected relative to the 
attention accorded to etiology and diagnosis. Finally, we advocate a stronger engagement with patients, 
therapy professionals, prescribers and psychopharmacologists.  
 
Brain function is realized in efficient performance of computations that best serve human needs. 
Computational psychiatry is a discipline which exploits the notion that understanding deviations from 
this ideal will help understand psychiatric disorders, with important implications for treatment. The 
field progresses in two directions simultaneously: top-down, (formally computational, i.e. starting from 
normative ideas), and bottom-up, starting from neural constraints (implementational). The field has 
enjoyed success largely because of its exploitation of new tools that connect these levels. An important 
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new bridge between top-down and bottom-up perspectives has been explicit modeling of the brain as a 
decision-maker operating in an uncertain world (probabilistic inference). This has helped elucidate 
existing findings, especially in biological reinforcement learning and allowed testing of hypotheses 
about information processing at the level of systems neuroscience, especially in the context of analysis 
of brain imaging data.  
 
New vistas on psychopathology are now been opened up. There is a much-needed emphasis in 
rethinking psychiatric nosology in terms of computational mechanisms using constraints from all levels 
of analysis. A closer integration between animal and human research has led to an important focus on 
conserved computations and their implementation. A wide spectrum of probabilistic cognition, from 
sensory perception to social decision-making is being analyzed. At the level of whole human brain, 
there is a rich exploitation of technologies such as high-field fMRI and MEG, often employing 
sophisticated methods informed by a Bayesian framework (1). Complementary approaches are 
provided by biological neural network modeling, where computational psychiatry has enthusiastically 
embraced developments in machine learning. Neuroscientific insights stemming from progress in deep 
learning neural networks are also emerging (2) and here neuropsychiatric applications are awaited with 
excitement. At the epidemiological level, computational analyses are increasingly applied to 
populations, especially longitudinal informed data (3). Population studies are starting to use machine 
learning data-driven approaches to improve diagnosis.  
   
Early computational psychiatry studies, often produced modest or difficult to interpret results, a 
situation that can be improved by addressing important limitations. First, the ecological validity of 
computational tasks in addressing psychopathology needs addressing. Tasks are needed that accurately 
assess psychiatrically relevant individual differences, aiming to elucidate features beyond neurotypical 
mechanisms, for instance by means of emotionally engaging experimental manipulations (4). 
Furthermore, computational psychiatry is likely to benefit by looking beyond behaviors that only 
extend to a timescale of minutes (typically during interactions with a computer in a laboratory). Here it 
is important to appreciate that many aspects of psychiatric disorders emerge from dynamical processes 
that evolve over timescales of weeks or months (5) and are tightly linked to the specific context of a 
person’s life. The advent of mobile technologies (6) can provide an economically realistic means for 
studying behavior over such long time scales that necessarily embraces a  participant’s personal 
context.    
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Inspired by progress in other branches of medicine (e.g. stroke research), we expect that the 
implementation of psychiatrically relevant computations in the brain is heterogeneous. Individual brain 
differences most probably form the substrates for vulnerability, but also resilience and recovery  (7). 
This highlights a need to fully characterize heterogeneity in subclinical participants, seeking out 
‘differences that make a difference’ in generating symptoms. The importance of subclinical 
participants, particularly those experiencing substantial symptoms but who do not fulfill diagnostic 
criteria for a disorder, is that they are relatively free of confounds that arise from treatments and 
secondary deficits as seen in clinically diagnosed patients. Subclinical participants in effect can form an 
optimal testing ground for the development of tasks sensitive to symptoms. How (and in whom) 
mechanisms lead to clinical disorders can then be addressed.  In short, we propose that the field move 
from a largely case-control approach to a stepped individual-variability approach.  
 
Computational psychiatry may be like a gifted, confident, teenager who hasn't had the chance to come 
across real disappointments and discover the value of complex interdependence. Whether or not 
psychiatric ill health turns out to have ‘natural joints’ to ‘carve’, computational psychiatry can also 
flourish through cultivating its inter-dependencies with the broader mental health economy. The first 
inter-dependency is with patients and front-line staff, specifically addressing the role of learning as part 
of therapy. Learning-based treatments primarily concern rehabilitation and wellbeing, not necessarily 
symptom elimination (8).  Psycho-education is essential, and here the twin lenses of the brain-as-
updater-of-beliefs (the ‘Bayesian brain’) and the brain-as-seeker-of-well-being (the ‘neuroeconomic 
brain’) are notions easily accessible to patients and staff (Figure 1). More generally, as well as asking 
'how can we treat the patient's symptoms, e.g. delusions?' a recovery approach asks 'how can the patient 
best pursue their life goals given residual symptoms?' This therapeutic target can be naturally pursued 
by computational psychiatry, as it deals with optimal decision-making. In turn this suggests opening up 
a new domain of research to support adaptive mechanisms, rather than treat etiologic mechanisms, by 
means of behavioral interventions and pharmacological agents that that have a potential to improve 
learning and decision-making.  
 
[Figure 1 here] 
The second inter-dependency is with prescribers and psychopharmacologists. Prescribers need optimal 
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treatment algorithms to use with existing drugs. They are less interested in how a relative safe drug, say 
Citalopram, functions than in whom it will not work (and hence likely to benefit from alternatives such 
as Venlafaxine, Quetiapine, or Lithium). We should therefore direct research at these neglected groups, 
namely those who are not likely to improve using current clinical algorithms.  
Finally, the most lucrative and ethically most demanding inter-dependency is with drug developers. 
Here computational psychiatry could help enhance the power of animal research. As an example, β-
CaMKII activity in the lateral habenula enhances spike output of lateral habenula neurons and induces 
depression-like behaviours, akin to  anhedonia and behavioral despair (9). Insights can emerge by 
elucidating the computations through which neural structures process aversive information. This would 
help reconcile animal findings with seemingly conflicting data from patients, which has suggested 
depression is associated with attenuated habenula activity (10). Thus, computational psychiatry can 
help triangulate animal and human findings, ensuring that comparable - neurotypical or atypical - 
neurocomputational processes are considered to enable development of valid assays for novel 
therapeutic drugs. 
In conclusion, computational psychiatry is beginning to flourish as a discipline but has made few 
clinically useful discoveries. The field can benefit from establishing a richer and more comprehensive 
industry of systematic task development, sensitive to relevant individual differences. We also suggest 
an extension of its focus in order to study a resilient-to-diseased spectrum across individuals (‘nature’), 
exposures (‘nurture’) and development (longitudinally). Finally, computational psychiatry needs to 
engage with the priorities of key mental health stakeholders so as to develop treatment paradigms that 
do not solely focus on disease aetiology but embrace disorder management.  
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Figure 1. Slide from a psycho-educational presentation we administer to patients with medically 
unexplained symptoms, e.g. non-epileptic seizures (NES). It illustrates what the brain does in terms of 
Bayesian inference. This can help resolve 'psychological-neurological' conflicts. NESs, for example, 
can be seen as understandable but maladaptive decisions that a biologically sensitized brain has learnt 
to make, similar to other biological ‘emergency reactions’ found in animals (e.g. freezing, defensive 
paralysis) and humans (dissociative analgesia; cf. neurosymptoms.org/#/attack-treatment/4533198184 
). This framework deconstructs the common stigma ‘it’s all in your mind’. We then examine the context 
and stages involved in this maladaptive inference and help patients make more helpful inferences. 
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